Pharmacological Approaches to Understand, Prevent, and Mitigate Hurting Memories. Lessons from Posttraumatic Stress Disorders

作者: Hans-Peter Kapfhammer , M Linden , K Rutkowski

DOI: 10.1016/B978-0-12-398393-0.00003-1

关键词:

摘要: Memory disturbances are among the diagnostic core features of posttraumatic stress disorder (PTSD). These may present as involuntary intrusive trauma-related recollections on one hand and deficits in autobiographical memory other. There is no linear obligatory relation between trauma exposition PTSD. Several neurobiological, psychological, psychosocial factors risk resilience mediate a complex differential development reactions. From preventive therapeutic perspective, it would be paramount importance to have effective psychological or pharmacological tools at mitigate even prevent any primary overconsolidation traumatic memory.

参考文章(75)
Joseph Zohar, Alzbeta Juven-Wetzler, Hagit Cohen, Rachel Sonnino, Can posttraumatic stress disorder be prevented Cns Spectrums. ,vol. 14, pp. 44- 51 ,(2009)
O Bonne, T Peri, E Gelpin, D Brandes, A Y Shalev, Treatment of recent trauma survivors with benzodiazepines: a prospective study. The Journal of Clinical Psychiatry. ,vol. 57, pp. 390- 394 ,(1996)
Steven M Southwick, Elizabeth Frazier, Ann Rasmusson, Lori L Davis, Charles Ward, Jason M Newell, A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacology Bulletin. ,vol. 41, pp. 8- 18 ,(2008)
Janet Metcalfe, W. Jake Jacobs, Emotional memory: The effects of stress on "cool" and "hot" memory systems. Psychology of Learning and Motivation. ,vol. 38, pp. 187- 222 ,(1998) , 10.1016/S0079-7421(08)60187-5
Joseph Zohar, Alzbeta Juven-Wetzler, Shlomit Cwikel-Hamzany, Evgenya Balaban, Hagit Cohen, Rachel Sonnino, New insights into secondary prevention in post-traumatic stress disorder Dialogues in clinical neuroscience. ,vol. 13, pp. 301- 309 ,(2011)
J. Douglas Bremner, Bernet Elzinga, Christian Schmahl, Eric Vermetten, Structural and functional plasticity of the human brain in posttraumatic stress disorder. Progress in Brain Research. ,vol. 167, pp. 171- 186 ,(2008) , 10.1016/S0079-6123(07)67012-5
Elizabeth A. Hoge, John J. Worthington, John T. Nagurney, Yuchiao Chang, Elaine B. Kay, Christine M. Feterowski, Anna R. Katzman, Jared M. Goetz, Maria L. Rosasco, Natasha B. Lasko, Randall M. Zusman, Mark H. Pollack, Scott. P. Orr, Roger K. Pitman, Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neuroscience & Therapeutics. ,vol. 18, pp. 21- 27 ,(2012) , 10.1111/J.1755-5949.2010.00227.X
Gustav Schelling, Post-traumatic stress disorder in somatic disease: lessons from critically ill patients. Progress in Brain Research. ,vol. 167, pp. 229- 237 ,(2008) , 10.1016/S0079-6123(07)67016-2
ROBERT FREEDMAN, Neurobiology of Mental Illness, 3rd ed. American Journal of Psychiatry. ,vol. 166, pp. 1072- 1073 ,(2009) , 10.1176/APPI.AJP.2009.09060873
Sherri Sharp, Christopher Thomas, Laura Rosenberg, Marta Rosenberg, Walter Meyer, Propranolol does not reduce risk for acute stress disorder in pediatric burn trauma Journal of Trauma-injury Infection and Critical Care. ,vol. 68, pp. 193- 197 ,(2010) , 10.1097/TA.0B013E3181A8B326